2 news items
CORE LAB REPORTS FIRST QUARTER 2024 RESULTS
24 Apr 24
quarter-end. The Company will continue applying future free cash towards reducing debt until the Company reaches its target leverage ratio (calculated
B of A Securities Maintains Underperform on Core Laboratories, Lowers Price Target to $16
15 Apr 24
B of A Securities analyst Chase Mulvehill maintains Core Laboratories (NYSE:CLB) with a Underperform and lowers the price target from $17 to $16.
- Prev
- 1
- Next